Literature DB >> 27629273

Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome.

Margaret A Mariano1, Kerri Tang1, Matthew Kurtz2,3, Wendy R Kates1.   

Abstract

AIM: Schizophrenia and 22q11.2 deletion syndrome (22q11DS) share similar patterns of cognitive deficits. Up to 30% of those with 22q11DS develop schizophrenia during early adulthood. As cognitive decline has recently been found to predict onset of psychosis in adolescents with 22q11DS, early interventions such as cognitive remediation (CR) during adolescence are warranted. This paper investigates the durability of a remote, computerized, CR programme for youth with 22q11DS. Our aim was to determine if the positive effects of CR persisted 6 months beyond intervention completion.
METHODS: A longitudinal design with 21 participants serving as their own controls was used. Youth were seen for neurocognitive assessments at pre-treatment, after the targeted 8-month intervention, at post-treatment, and 6 months after for follow-up. During the intervention, cognitive coaches met remotely with participants for CR via video conferencing three times a week, and offered task-specific strategies. To determine if intervention improvements held across the 6-month follow-up period, neurocognitive measures were statistically examined with repeated measures analysis of variances from pre-treatment through follow-up.
RESULTS: Our CR intervention proved durable. Post-treatment improvements comprising cognitive flexibility, executive function, reaction time and working memory were maintained over the follow-up period.
CONCLUSIONS: Results confirm previous research regarding the durability of CR treatment and extend these findings to youth with 22q11DS. The present study may serve to inform early intervention efforts focused on cognitive and functionally relevant rehabilitation goals for youth with 22q11DS and suggests that 22q11DS can potentially serve as a suitable model for examining the trajectory preceding psychosis.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  22q11.2 deletion syndrome; adolescents; cognitive remediation; early intervention in psychosis; follow-up study

Mesh:

Year:  2016        PMID: 27629273      PMCID: PMC5352536          DOI: 10.1111/eip.12367

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  48 in total

1.  Cognitive development in children with 22q11.2 deletion syndrome.

Authors:  Sasja N Duijff; Petra W J Klaassen; Henriette F N Swanenburg de Veye; Frits A Beemer; Gerben Sinnema; Jacob A S Vorstman
Journal:  Br J Psychiatry       Date:  2012-06       Impact factor: 9.319

2.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

3.  Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  Arch Clin Neuropsychol       Date:  2006-10-02       Impact factor: 2.813

4.  Neurocognitive enhancement therapy with work therapy in schizophrenia: 6-month follow-up of neuropsychological performance.

Authors:  Morris Bell; Joanna Fiszdon; Tamasine Greig; Bruce Wexler; Gary Bryson
Journal:  J Rehabil Res Dev       Date:  2007

5.  Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Susan J Cooley; Ann Louise DiBarry; Debra M Montrose; Matcheri S Keshavan
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

6.  Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia.

Authors:  Melissa Fisher; Rachel Loewy; Cameron Carter; Ashley Lee; J Daniel Ragland; Tara Niendam; Danielle Schlosser; Lien Pham; Tara Miskovich; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2014-01-20       Impact factor: 9.306

7.  Persistence of effectiveness of cognitive remediation interventions in schizophrenia: a 1-year follow-up study.

Authors:  Giacomo Deste; Stefano Barlati; Paolo Cacciani; Luca DePeri; Roberto Poli; Emilio Sacchetti; Antonio Vita
Journal:  Schizophr Res       Date:  2014-12-19       Impact factor: 4.939

8.  Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome.

Authors:  Therese van Amelsvoort; Jayne Henry; Robin Morris; Michael Owen; Don Linszen; Kieran Murphy; Declan Murphy
Journal:  Schizophr Res       Date:  2004-10-01       Impact factor: 4.939

9.  A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis.

Authors:  Laurent Holzer; Sebastien Urben; Christina Moses Passini; Laure Jaugey; Michael H Herzog; Olivier Halfon; Sandrine Pihet
Journal:  Behav Cogn Psychother       Date:  2013-05-01

10.  Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial.

Authors:  Til Wykes; Elizabeth Newton; Sabine Landau; Christopher Rice; Neil Thompson; Sophia Frangou
Journal:  Schizophr Res       Date:  2007-05-23       Impact factor: 4.939

View more
  2 in total

1.  ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia.

Authors:  Cuiping Guo; Yi Liu; Mao-Sheng Fang; Yuanyuan Li; Wensheng Li; Yacoubou Abdoul Razak Mahaman; Kuan Zeng; Yiyuan Xia; Dan Ke; Rong Liu; Jian-Zhi Wang; Hui Shen; Xiji Shu; Xiaochuan Wang
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 7.620

2.  Childhood Executive Functioning Predicts Young Adult Outcomes in 22q11.2 Deletion Syndrome.

Authors:  Avery B Albert; Tamara Abu-Ramadan; Wendy R Kates; Wanda Fremont; Kevin M Antshel
Journal:  J Int Neuropsychol Soc       Date:  2018-10       Impact factor: 2.892

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.